It is important to note that, according to the release, approval has currently only been granted for certain individual blood biomarkers. According to the company’s website, the measurement currently includes around 250+ blood biomarkers, so we will still have to wait before the entire product can be sold in New York.
Quote from the press release:
…the laboratory must first obtain a clinical laboratory permit, after which the laboratory must submit validation data for each of its LDT tests, i.e., individual blood biomarkers included in the Nightingale Health Check service, for review by CLEP. The approvals now obtained are the first for Nightingale Health’s tests…
EDIT: fixed the broken formatting in the quote